Literature DB >> 8600516

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.

J W Burns1, M Siadat-Pajouh, A A Krishnaney, H B Greenberg.   

Abstract

Rotaviruses are the leading cause of severe gastroenteritis and dehydrating diarrhea in young children and animals worldwide. A murine model and "backpack tumor" transplantation were used to determine the protective effect of antibodies against VP4(an outer capsid viral protein) and VP6(a major inner capsid viral protein). Only two non-neutralizing immunoglobulin A (IgA) antibodies to VP6 were capable of preventing primary and resolving chronic murine rotavirus infections. These antibodies were not active, however, when presented directly to the luminal side of the intestinal tract. These findings support the hypothesis that in vivo intracellular viral inactivation by secretory IgA during transcytosis is a mechanism of host defense against rotavirus infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600516     DOI: 10.1126/science.272.5258.104

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  142 in total

1.  Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion.

Authors:  M Mathieu; I Petitpas; J Navaza; J Lepault; E Kohli; P Pothier; B V Prasad; J Cohen; F A Rey
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

Review 2.  Genetic and structural determinants of virus neutralizing antibodies.

Authors:  J E Crowe; R O Suara; S Brock; N Kallewaard; F House; J H Weitkamp
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 3.  Secretory IgA: arresting microbial pathogens at epithelial borders.

Authors:  Nicholas J Mantis; Stephen J Forbes
Journal:  Immunol Invest       Date:  2010       Impact factor: 3.657

4.  B2 but not B1 cells can contribute to CD4+ T-cell-mediated clearance of rotavirus in SCID mice.

Authors:  N Kushnir; N A Bos; A W Zuercher; S E Coffin; C A Moser; P A Offit; J J Cebra
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Impairment by mucosal adjuvants and cross-reactivity with variant peptides of the mucosal immunity induced by injection of the fusion peptide PADRE-ELDKWA.

Authors:  Nipa Decroix; Perayot Pamonsinlapatham; Cahn P Quan; Jean-Pierre Bouvet
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

6.  Characterization of serotype G9 rotavirus strains isolated in the United States and India from 1993 to 2001.

Authors:  A R Laird; J R Gentsch; T Nakagomi; O Nakagomi; R I Glass
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model.

Authors:  Huimin Yan; Michael E Lamm; Ewa Björling; Yung T Huang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

Review 8.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

9.  Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.

Authors:  F J Enriquez; M W Riggs
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches.

Authors:  K J Silvey; A B Hutchings; M Vajdy; M M Petzke; M R Neutra
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.